NORDICCELL ApS: Financial statements 2024
CVR: 27293972
Source: annual report 2024, Danish Business Authority
01/07/2023 – 30/06/2024
NORDICCELL ApS (CVR 27293972) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 8,346,541 and a net result of DKK 1,272,903 compared with DKK 3,575,860 the year before. That is a decrease of 29.5% compared with the year before. Equity in the 2024 report amounted to DKK 4,974,883. The solvency ratio was 40.9%. The company had 14 employees in the financial year.
- Gross Profit
- DKK 8,346,541
- Profit/Loss
- DKK 1,272,903
- Equity
- DKK 4,974,883
- Total Assets
- DKK 12,162,825
- Employees
- 14
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 8.3 mio. | 1.3 mio. | 5 mio. | 14 |
| 2023 | - | 11.8 mio. | 3.6 mio. | 7.2 mio. | 12 |
| 2022 | - | 13 mio. | 4.2 mio. | 7.8 mio. | 10 |
| 2021 | - | 10.8 mio. | 3.7 mio. | 7.3 mio. | 9 |
| 2020 | - | 8.6 mio. | 2.9 mio. | 4.3 mio. | 9 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningAbout NORDICCELL ApS
NORDICCELL ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2003. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Anders Bek-Pedersen. The company is owned by BEK-PEDERSEN HOLDING ApS. The company has 11 employees (2026). In 2025, the company reported a gross profit of DKK 8,909,296 and a net result of DKK 1,701,475 compared with DKK 1,272,903 the year before. Equity in the 2025 report amounted to DKK 4,976,358.